urea has been researched along with Behavior Disorders in 21 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We measured the serum levels of calcium, ionized calcium, inorganic phosphorus, alkaline phosphatase, albumin, parathyroid hormone (PTH), urea, creatinine, 25-hydroxy-vitamin D and lithium of 35 patients diagnosed with bipolar disorder in use of lithium carbonate (LC) for at least one year (Lithium Group - LG) and 35 healthy subjects (Control Group - CG)." | 3.80 | Evaluation of parathyroid function and mineral metabolism in psychiatric patients using lithium salts. ( Aguiar-Oliveira, MH; Campos Neto, IA; Oliveira, TC; Pereira, Fde A, 2014) |
| "Neuropsychiatric symptoms are common in Alzheimer's disease (AD) and other neurodegenerative disorders." | 2.52 | Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease. ( Cummings, J; Zhong, K, 2015) |
| "The objective is to investigate coronavirus disease 2019 (COVID-19)-associated neurological and psychiatric effects and explore possible pathogenic mechanisms." | 1.72 | Neurological and psychiatric presentations associated with COVID-19. ( He, X; Hu, X; Pan, K; Yu, H; Zhang, D; Zhang, G; Zhang, L; Zheng, X, 2022) |
| "Pimavanserin is a new 5-HT2A receptor acting drug that has been given market authorization for psychosis in Parkinson׳s disease." | 1.46 | Inverse agonists - What do they mean for psychiatry? ( Blier, P; Drago, F; Nutt, D; Stahl, S; Wilson, S; Zohar, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (76.19) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| He, X | 1 |
| Zhang, D | 1 |
| Zhang, L | 2 |
| Zheng, X | 1 |
| Zhang, G | 1 |
| Pan, K | 1 |
| Yu, H | 1 |
| Hu, X | 1 |
| Oliveira, TC | 1 |
| Campos Neto, IA | 1 |
| Aguiar-Oliveira, MH | 1 |
| Pereira, Fde A | 1 |
| Cummings, J | 1 |
| Zhong, K | 1 |
| Nutt, D | 1 |
| Stahl, S | 1 |
| Blier, P | 1 |
| Drago, F | 1 |
| Zohar, J | 1 |
| Wilson, S | 1 |
| ELSASSER, G | 1 |
| BAYREUTHER, H | 1 |
| BOBON, J | 1 |
| COLLARD, J | 1 |
| DEMARET, A | 1 |
| BRUNE, GG | 1 |
| HOHL, HH | 1 |
| HIMWICH, HE | 1 |
| ANDREWS, S | 1 |
| PARSONS, TC | 1 |
| BREMNER, JD | 1 |
| BARUCCI, M | 1 |
| Arroyo, A | 1 |
| Rosel, P | 1 |
| Marron, T | 1 |
| Leeming, RJ | 1 |
| Blair, JA | 1 |
| Omenn, GS | 1 |
| Losowsky, MS | 1 |
| Scott, BB | 1 |
| Francis, I | 1 |
| Gjesdal, K | 1 |
| Stromme, JH | 1 |
| Tyler, HR | 1 |
| Bjerstaf, L | 1 |
| Bjurwill, B | 1 |
| Ekman, B | 1 |
| Haeger, K | 1 |
| Ordell, R | 1 |
| Zick, WH | 1 |
| Kerry, RJ | 1 |
| Owen, G | 1 |
| Griffiths, H | 1 |
| Randall, ZC | 1 |
| Davies, HM | 1 |
3 reviews available for urea and Behavior Disorders
| Article | Year |
|---|---|
Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease.
Topics: Alzheimer Disease; Apathy; Citalopram; Clinical Trials as Topic; Cognition Disorders; Humans; Mental | 2015 |
Inborn errors of metabolism: clues to understanding human behavioral disorders.
Topics: Adrenal Hyperplasia, Congenital; Brain; Galactosemias; Glycine; Hepatolenticular Degeneration; Heter | 1976 |
Hepatic encephalopathy.
Topics: Acetazolamide; Ammonia; Constipation; Diet Therapy; Electroencephalography; Gastrointestinal Hemorrh | 1973 |
18 other studies available for urea and Behavior Disorders
| Article | Year |
|---|---|
Neurological and psychiatric presentations associated with COVID-19.
Topics: C-Reactive Protein; China; COVID-19; Cystatin C; Humans; Interleukin-10; Mental Disorders; Nervous S | 2022 |
Evaluation of parathyroid function and mineral metabolism in psychiatric patients using lithium salts.
Topics: Adult; Aged; Alkaline Phosphatase; Bipolar Disorder; Calcium; Case-Control Studies; Creatinine; Cros | 2014 |
Inverse agonists - What do they mean for psychiatry?
Topics: Animals; Humans; Mental Disorders; Piperidines; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 R | 2017 |
[Hallucinations in chronic misuse of adaline; manifestations and clinical aspects of exogenic psychotic syndromes].
Topics: Bridged-Ring Compounds; Hallucinations; Humans; Mental Disorders; Piperidines; Psychotic Disorders; | 1956 |
[Use & mechanism of action of sulfonamide derivatives decreasing the blood sugar in insulin shock therapy in psychiatry].
Topics: Blood Glucose; Convulsive Therapy; Humans; Insulin; Insulin Coma; Mental Disorders; Psychiatry; Sulf | 1957 |
[A new neuroleptic with delayed hypnogenic effect: dipiperon (R3345), butyrophenone carbamide].
Topics: Antipsychotic Agents; Butyrophenones; Mental Disorders; Tranquilizing Agents; Urea | 1961 |
URINARY EXCRETION OF BUFOTENIN-LIKE SUBSTANCE IN PSYCHOTIC PATIENTS.
Topics: 1-Propanol; Acetates; Alcohols; Alkaloids; Ammonia; Bufotenin; Chromatography; Hallucinogens; Humans | 1963 |
BLOOD BROMIDE LEVELS IN PSYCHIATRIC PATIENTS TAKING BROMUREIDES.
Topics: Blood; Bromides; Bromine; Drug Therapy; Humans; Mental Disorders; Patients; Substance-Related Disord | 1965 |
The use of urea in the management of post ictal confusion associated with cerebral and generalized edema.
Topics: Brain; Brain Diseases; Confusion; Edema; Edetic Acid; Electroconvulsive Therapy; Mental Disorders; S | 1962 |
[The blood-cerebrospinal fluid ratio of urea hypobromite in nervous and mental disease].
Topics: Anxiety; Blood; Language; Mental Disorders; Psychotic Disorders; Urea | 1950 |
Cerebrospinal fluid: postmortem biochemical study.
Topics: Age Factors; Aged; Alkaline Phosphatase; Calcium; Cause of Death; Cerebrospinal Fluid Proteins; Chlo | 2005 |
The effects of pathological and normal physiological processes on biopterin derivative levels in man.
Topics: Adolescent; Adult; Aged; Aging; Biopterins; Brain Chemistry; Child; Child, Preschool; Contraceptives | 1980 |
Incidence of bromureide use by psychiatric patients before and after introduction of restrictive legislation.
Topics: Australia; Bromides; Bromine; Female; Hospitalization; Humans; Legislation, Drug; Male; Mental Disor | 1974 |
Multiphasic screening programme for somatic diseases among elderly long-term psychiatric patients.
Topics: Adult; Aged; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Creatine Kinase; | 1974 |
Neurologic disorders seen in the uremic patient.
Topics: Blindness; Blood Urea Nitrogen; Blood-Brain Barrier; Brain; Cell Membrane Permeability; Electroencep | 1970 |
The effect on haematological and biochemical parameters by treatment with nortestosterone-3-(4-hexyloxyphenyl)-propionate.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Blood; Blood Protein | 1970 |
[Experience with the soporific Stiglidorm in the treatment of mental and affective disorders].
Topics: Affective Symptoms; Drug Synergism; Humans; Hypnotics and Sedatives; Mental Disorders; Methaqualone; | 1967 |
Changes in body water, weight and electrolytes in recurrent mental illness.
Topics: Body Weight; Depression; Female; Humans; Male; Mental Disorders; Urea; Water-Electrolyte Balance | 1968 |